Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 15 Sep 20 424B3 Prospectus supplement
- 6 Apr 20 EFFECT Notice of effectiveness
-
25 Mar 20 S-1 IPO registration
ELDN similar filings
Filing view
External links
Exhibit 23.2
Consent of Independent Registered Public Accounting Firm
We consent to the reference to our firm under the caption “Experts” and to the use of our report dated March 27, 2019, in the Registration Statement (FormS-1) and related Prospectus of Novus Therapeutics, Inc. for the registration of 7,243,135 shares of its common stock.
/s/ Ernst & Young LLP
Irvine, California
March 25, 2020